An acute internal jugular, subclavian, or axillary DVT is a relatively ... with an internal jugular vein thrombosis being the most common source. The inconsistent use of anticoagulation therapy ...

This study revealed chronic occlusion of the right axillary and distal subclavian vein with reconstitution of the central subclavian vein and patency of the superior vena cava (SVC). Numerous right ...

Following a multidisciplinary discussion, considering that the risk of cerebral hemorrhage has decreased, but the risk of thrombosis is still ... the right internal jugular vein. No thrombus was ...

A no-touch vein harvesting technique reduces vein graft occlusion and improves patient outcomes at three-year follow-up among ...

No-touch' vein harvesting significantly reduces the risk of graft failure up to three years after coronary artery bypass ...

The FDA has granted Priority Review status to Regeneron’s and Bayer’s supplemental Biologics License Application (sBLA) for Eylea HD (aflibercept) injection 8 mg. The application seeks to expand use ...

Gill, MD, discusses the potential FDA approval in 2025 of aflibercept 8 mg for the treatment of retinal vein occlusion. Gill, vice chair of clinical performance and ophthalmology professor at ...

According to a report from ESPN's Shams Charania, seven-time All-NBA guard and nine-time All-Star Damian Lillard has been cleared of the deep vein thrombosis in his right leg and is also no longer ...

No-touch’ vein harvesting significantly reduces the risk of graft failure up to three years after coronary artery bypass surgery compared with conventionally harvested vein grafts, finds a study from ...

Milwaukee Bucks star Damian Lillard has been cleared of his deep vein thrombosis and is no longer on blood-thinning medication. The Bucks did not disclose a timeline for Lillard's return Thursday ...